Home » Finance

Image for Compagnie Plastic Omnium (OTCMKTS:PASTF) Stock Rating Upgraded by JPMorgan Chase & Co.

Compagnie Plastic Omnium (OTCMKTS:PASTF) Stock Rating Upgraded by JPMorgan Chase & Co.

Compagnie Plastic Omnium (OTCMKTS:PASTF – Get Rating) was upgraded by JPMorgan Chase & Co. from an “underweight” rating to a “neutral” rating in a report released on Monday, The Fly reports. Compagnie... More of this article »
Image for Jefferies Financial Group (NYSE:JEF) Research Coverage Started at StockNews.com

Jefferies Financial Group (NYSE:JEF) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Jefferies Financial Group (NYSE:JEF – Get Rating) in a research report report published on Sunday morning. The brokerage issued a hold rating on the financial services provider’s... More of this article »
Image for Q1 2024 Earnings Forecast for Peraso Inc. (NASDAQ:PRSO) Issued By K LIU &

Q1 2024 Earnings Forecast for Peraso Inc. (NASDAQ:PRSO) Issued By K LIU &

Peraso Inc. (NASDAQ:PRSO – Get Rating) – Research analysts at K LIU & issued their Q1 2024 earnings per share (EPS) estimates for Peraso in a report issued on Thursday, March 23rd. K LIU & analyst K. Liu anticipates... More of this article »
Image for Research Analysts Set Expectations for American Tower Co.’s Q1 2024 Earnings (NYSE:AMT)

Research Analysts Set Expectations for American Tower Co.’s Q1 2024 Earnings (NYSE:AMT)

American Tower Co. (NYSE:AMT – Get Rating) – Research analysts at Zacks Research lowered their Q1 2024 earnings per share (EPS) estimates for American Tower in a research report issued to clients and investors on Thursday,... More of this article »
Image for Northern Technologies International (NASDAQ:NTIC) Earns Hold Rating from Analysts at StockNews.com

Northern Technologies International (NASDAQ:NTIC) Earns Hold Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Northern Technologies International (NASDAQ:NTIC – Get Rating) in a research report sent to investors on Sunday morning. The firm issued a hold rating on the specialty chemicals company’s... More of this article »
Image for Lakeland Bancorp (NASDAQ:LBAI) Research Coverage Started at StockNews.com

Lakeland Bancorp (NASDAQ:LBAI) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Lakeland Bancorp (NASDAQ:LBAI – Get Rating) in a research note issued to investors on Sunday morning. The brokerage issued a hold rating on the financial services provider’s stock. Lakeland... More of this article »
Image for Umpqua (NASDAQ:UMPQ) Research Coverage Started at StockNews.com

Umpqua (NASDAQ:UMPQ) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Umpqua (NASDAQ:UMPQ – Get Rating) in a research note issued to investors on Sunday. The brokerage issued a sell rating on the bank’s stock. Separately, Wells Fargo & Company... More of this article »
Image for Aeglea BioTherapeutics (NASDAQ:AGLE) Earns Hold Rating from Analysts at StockNews.com

Aeglea BioTherapeutics (NASDAQ:AGLE) Earns Hold Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Get Rating) in a research report sent to investors on Sunday. The brokerage issued a hold rating on the biotechnology company’s stock. Separately,... More of this article »
Image for Onconova Therapeutics (NASDAQ:ONTX) Research Coverage Started at StockNews.com

Onconova Therapeutics (NASDAQ:ONTX) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Get Rating) in a research report released on Sunday. The firm issued a hold rating on the biopharmaceutical company’s stock. Onconova Therapeutics... More of this article »
Image for StockNews.com Initiates Coverage on Rubicon Technology (NASDAQ:RBCN)

StockNews.com Initiates Coverage on Rubicon Technology (NASDAQ:RBCN)

Equities researchers at StockNews.com assumed coverage on shares of Rubicon Technology (NASDAQ:RBCN – Get Rating) in a research report issued on Monday. The brokerage set a “sell” rating on the semiconductor company’s... More of this article »
Image for The Goldman Sachs Group Lowers Fuji Electric (OTCMKTS:FELTY) to Buy

The Goldman Sachs Group Lowers Fuji Electric (OTCMKTS:FELTY) to Buy

The Goldman Sachs Group lowered shares of Fuji Electric (OTCMKTS:FELTY – Get Rating) from a conviction-buy rating to a buy rating in a report issued on Sunday, The Fly reports. Fuji Electric Stock Performance Shares of FELTY... More of this article »
Image for Shore Capital Reaffirms “House Stock” Rating for Destiny Pharma (LON:DEST)

Shore Capital Reaffirms “House Stock” Rating for Destiny Pharma (LON:DEST)

Shore Capital restated their house stock rating on shares of Destiny Pharma (LON:DEST – Get Rating) in a research report report published on Saturday morning, Marketbeat reports. Destiny Pharma Stock Down 2.4 % Destiny Pharma... More of this article »
Image for Darden Restaurants, Inc. (NYSE:DRI) Forecasted to Post FY2023 Earnings of $7.95 Per Share

Darden Restaurants, Inc. (NYSE:DRI) Forecasted to Post FY2023 Earnings of $7.95 Per Share

Darden Restaurants, Inc. (NYSE:DRI – Get Rating) – Stock analysts at Wedbush increased their FY2023 earnings per share (EPS) estimates for shares of Darden Restaurants in a research report issued on Friday, March 24th.... More of this article »
Image for Brokers Set Expectations for Fortuna Silver Mines Inc.’s FY2023 Earnings (TSE:FVI)

Brokers Set Expectations for Fortuna Silver Mines Inc.’s FY2023 Earnings (TSE:FVI)

Fortuna Silver Mines Inc. (TSE:FVI – Get Rating) (NYSE:FSM) – National Bank Financial reduced their FY2023 earnings estimates for Fortuna Silver Mines in a note issued to investors on Wednesday, March 22nd. National... More of this article »
Image for Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) Coverage Initiated by Analysts at StockNews.com

Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSEAMERICAN:AMPE – Get Rating) in a research report sent to investors on Saturday. The firm issued a sell rating on the specialty pharmaceutical company’s... More of this article »
Image for StockNews.com Upgrades Compañía de Minas Buenaventura S.A.A. (NYSE:BVN) to Hold

StockNews.com Upgrades Compañía de Minas Buenaventura S.A.A. (NYSE:BVN) to Hold

StockNews.com upgraded shares of Compañía de Minas Buenaventura S.A.A. (NYSE:BVN – Get Rating) from a sell rating to a hold rating in a research note published on Saturday. Compañía de Minas Buenaventura S.A.A. Trading Up... More of this article »
Image for Stifel Firstegy Equities Analysts Decrease Earnings Estimates for Canadian Natural Resources Limited (TSE:CNQ)

Stifel Firstegy Equities Analysts Decrease Earnings Estimates for Canadian Natural Resources Limited (TSE:CNQ)

Canadian Natural Resources Limited (TSE:CNQ – Get Rating) (NYSE:CNQ) – Equities research analysts at Stifel Firstegy decreased their Q1 2023 earnings estimates for shares of Canadian Natural Resources in a research note... More of this article »
Image for Par Pacific Holdings, Inc. (NYSE:PARR) Receives $28.57 Consensus Target Price from Analysts

Par Pacific Holdings, Inc. (NYSE:PARR) Receives $28.57 Consensus Target Price from Analysts

Shares of Par Pacific Holdings, Inc. (NYSE:PARR – Get Rating) have been assigned an average recommendation of “Moderate Buy” from the eight research firms that are covering the stock, MarketBeat Ratings reports.... More of this article »
Image for Thermo Fisher Scientific (NYSE:TMO) Cut to “Hold” at StockNews.com

Thermo Fisher Scientific (NYSE:TMO) Cut to “Hold” at StockNews.com

StockNews.com cut shares of Thermo Fisher Scientific (NYSE:TMO – Get Rating) from a buy rating to a hold rating in a research note issued to investors on Sunday. Other research analysts have also issued reports about the company.... More of this article »
Image for Oppenheimer Comments on Vor Biopharma Inc.’s Q1 2023 Earnings (NYSE:VOR)

Oppenheimer Comments on Vor Biopharma Inc.’s Q1 2023 Earnings (NYSE:VOR)

Vor Biopharma Inc. (NYSE:VOR – Get Rating) – Analysts at Oppenheimer issued their Q1 2023 earnings per share (EPS) estimates for shares of Vor Biopharma in a research note issued to investors on Thursday, March 23rd.... More of this article »
Image for Bridgeline Digital (NASDAQ:BLIN) Research Coverage Started at StockNews.com

Bridgeline Digital (NASDAQ:BLIN) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Bridgeline Digital (NASDAQ:BLIN – Get Rating) in a research report sent to investors on Sunday morning. The firm issued a hold rating on the software maker’s stock. Separately,... More of this article »
Image for StockNews.com Begins Coverage on Cowen (NASDAQ:COWN)

StockNews.com Begins Coverage on Cowen (NASDAQ:COWN)

StockNews.com assumed coverage on shares of Cowen (NASDAQ:COWN – Get Rating) in a report issued on Sunday. The firm issued a sell rating on the financial services provider’s stock. Cowen Stock Performance COWN stock opened... More of this article »
Image for StockNews.com Begins Coverage on Innovative Solutions and Support (NASDAQ:ISSC)

StockNews.com Begins Coverage on Innovative Solutions and Support (NASDAQ:ISSC)

StockNews.com initiated coverage on shares of Innovative Solutions and Support (NASDAQ:ISSC – Get Rating) in a research report released on Sunday. The firm issued a buy rating on the aerospace company’s stock. Innovative... More of this article »
Image for Yamana Gold (NYSE:AUY) Earns Hold Rating from Analysts at StockNews.com

Yamana Gold (NYSE:AUY) Earns Hold Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Yamana Gold (NYSE:AUY – Get Rating) (TSE:YRI) in a research report released on Sunday morning. The firm issued a hold rating on the basic materials company’s stock. Other analysts... More of this article »
Image for StockNews.com Initiates Coverage on NovaBay Pharmaceuticals (NYSE:NBY)

StockNews.com Initiates Coverage on NovaBay Pharmaceuticals (NYSE:NBY)

StockNews.com initiated coverage on shares of NovaBay Pharmaceuticals (NYSE:NBY – Get Rating) in a research note issued to investors on Sunday. The firm issued a hold rating on the stock. NovaBay Pharmaceuticals Price Performance Shares... More of this article »